Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cross Coupling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113620951B discloses novel phosphorescent host materials improving OLED efficiency and lifetime via optimized Pd-catalyzed coupling.
Patent CN114096529A details a scalable route for Asciminib intermediates using improved Suzuki coupling and amide formation, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN106008318B reveals advanced chiral dye synthesis for OLED. Discover cost reduction in electronic chemical manufacturing and high-purity supply solutions.
Novel palladium-catalyzed route for Vonoprazan fumarate intermediates ensures high purity and supply chain stability for global pharmaceutical manufacturing.
Advanced mid-infrared liquid crystal compounds with high transmittance. Efficient synthesis reduces costs for display and optoelectronic material manufacturing supply chains.
Advanced synthesis of histamine H3 receptor ligands via Pd-catalyzed coupling. Offers scalable routes for respiratory and CNS drug development with optimized purity.
Patent CN102516118B details a room-temperature Pd-catalyzed route for high-purity liquid crystal materials, offering significant cost reduction and supply chain reliability for electronic chemical manufacturing.
Patent CN118047661B reveals a novel Ni-catalyzed route for isomeric high-carbon alcohols, offering sustainable production and cost-effective supply chain solutions for global industries.
Patent CN109651344A reveals a green CuBr-catalyzed method for triarylmethane compounds, offering significant cost reduction in fine chemical manufacturing and high-purity outcomes.
Novel Pd-catalyzed one-step coupling for high-purity 2-cyano-4'-methyl biphenyl. Reduces cost and improves supply chain reliability for antihypertensive drug manufacturing.
Novel Pd-catalyzed method for unsaturated nitriles using boronic acids. High yield, scalable process for pharma intermediates. Cost-effective supply chain solution.
Novel Ni-catalyzed difluoroalkylation offers mild conditions and cost efficiency for high-purity isoquinoline-1,3-dione manufacturing.
Patent CN108299141A details a mild copper-catalyzed route for alpha-selective alkenes. This method offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Novel nickel-catalyzed route for a-BPDA production offers significant cost reduction and simplified processing for high-performance polyimide manufacturing supply chains.
Patent CN101445437A reveals a cost-effective Cu/imidazole catalytic system for diaryl ethers, offering reliable pharmaceutical intermediate supply chains.
Patent CN100341875C reveals a novel nickel-catalyzed process for herbicide intermediates. Achieve cost reduction in herbicide manufacturing with high-purity scalable routes.
Patent CN101052633A details efficient indazole synthesis for kinase inhibitors. Discover cost reduction in API manufacturing and scalable production methods.
Patent CN1033391C details advanced catalytic routes for metabolically stable beta-carboline derivatives, offering cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN101151256B details a novel palladium-catalyzed route for 11-alkylidene dibenzoxepins, offering superior stereocontrol and cost reduction in pharmaceutical manufacturing.
Patent CN104692985A details a mild palladium-catalyzed route for alpha-aryl-alpha-alpha-difluoroallyl structures, offering significant supply chain and cost advantages for pharmaceutical intermediate manufacturing.